Compound 1671
Identifiers
- Common name: NPD199
- Canonical SMILES:
Oc1cc(OCc2ccccc2)ccc1C(=O)NCc1cccc(c1)N(=O)=O
- IUPAC name:
4-(benzyloxy)-2-hydroxy-N-[(3-nitrophenyl)methyl]benzamide
- InChi:
InChI=1S/C21H18N2O5/c24-20-12-18(28-14-15-5-2-1-3-6-15)9-10-19(20)21(25)22-13-16-7-4-8-17(11-16)23(26)27/h1-12,24H,13-14H2,(H,22,25)
- InChiKey:
BMGQFBABFVSNBK-UHFFFAOYSA-N
External links
![]() 71453834 |
![]() CHEMBL2180478 |
External search
![]() |
![]() |
![]() |
![]() |
![]() |
Bibliography (1)
Pharmacological data
Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|
1 | 0 | 0 | 0 |
Targets
PPI family | Best activity | Diseases | MMoA |
---|---|---|---|
LEDGF / IN | 5.42 | HIV infectious disease | Inhibition |
Physicochemical filters
Descriptor | Lipinski's RO5 | Veber | Pfizer's 3/75 | |
---|---|---|---|---|
Compliance | ||||
MW | 378.12 g/mol | |||
HBA | 7 | |||
HBD | 2 | |||
HBA + HBD | 9 | |||
AlogP | 4.63 | |||
TPSA | 104.38 | |||
RB | 7 |
Radar chart
PCA : iPPI-DB chemical space
PCA : Correlation circle
Efficiencies: iPPI-DB biplot LE versus LLE
Summary
Bibliographic ressources | Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|---|
1 | 1 | 0 | 0 | 0 |
Ta | Structure | Name | Drugbank ID |
---|---|---|---|
0.5565 | Picotamide | DB13327 | |
0.5538 | (5-CHLORO-2-{[(3-NITROBENZYL)AMINO]CARBONYL}PHENOXY)ACETIC ACID | DB07030 | |
0.5321 | Trimethobenzamide | DB00662 | |
0.5179 | Clefamide | DB13512 | |
0.5093 | Itopride | DB04924 | |
0.5044 | 4-PHENOXY-N-(PYRIDIN-2-YLMETHYL)BENZAMIDE | DB07459 | |
0.4954 | Aminaphthone | DB13039 | |
0.4948 | Tucaresol | DB13027 | |
0.4865 | Priralfinamide | DB06649 | |
0.4865 | Safinamide | DB06654 | |
0.4804 | Phenyl aminosalicylate | DB06807 | |
0.4800 | Etamivan | DB08989 | |
0.4766 | Aniracetam | DB04599 | |
0.4746 | Bromopride | DB09018 | |
0.4685 | 4-{2-[(3-Nitrobenzoyl)Amino]Phenoxy}Phthalic Acid | DB04044 |